StockData
Nephros Inc logo

Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3020% below fair value
$2.90−0.10 (-3.33%)

Close on Nov 17, 2026Market cap $31.49MP/E 18.1Yield –

Nephros operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nephros's operating cash flow for the twelve months ending Jun 30, 2026 was -$706.00K, down 135.4% year over year. For fiscal 2025 it was $1.60M. The highest annual figure on record is $1.60M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.60M–
FY2024Dec 31, 2024-$492.00K-159.5%
FY2023Dec 31, 2023$827.00K–
FY2022Dec 31, 2022-$3.23M–
FY2021Dec 31, 2021-$1.42M–
FY2020Dec 31, 2020-$6.90M–
FY2019Dec 31, 2019-$2.28M–
FY2018Dec 31, 2018-$3.66M–
FY2017Dec 31, 2017-$77.00K–
FY2016Dec 31, 2016-$2.11M–
FY2015Dec 31, 2015-$3.82M–
FY2014Dec 31, 2014-$2.50M–
FY2013Dec 31, 2013-$3.58M–
FY2012Dec 31, 2012-$1.55M–
FY2011Dec 31, 2011-$1.30M–
FY2010Dec 31, 2010-$1.29M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$681.00K-31.5%
Q1 FY2026Mar 31, 2026-$1.67M-618.9%
Q4 FY2025Dec 31, 2025$185.00K-85.8%
Q3 FY2025Sep 30, 2025$99.00K–
Q2 FY2025Jun 30, 2025$994.00K–
Q1 FY2025Mar 31, 2025$322.00K–
Q4 FY2024Dec 31, 2024$1.30M–
Q3 FY2024Sep 30, 2024-$623.00K-210.9%
Q2 FY2024Jun 30, 2024-$501.00K-321.7%
Q1 FY2024Mar 31, 2024-$672.00K-343.5%
Q4 FY2023Dec 31, 2023-$237.00K–
Q3 FY2023Sep 30, 2023$562.00K–
Q2 FY2023Jun 30, 2023$226.00K–
Q1 FY2023Mar 31, 2023$276.00K–
Q4 FY2022Dec 31, 2022-$195.00K–
Q3 FY2022Sep 30, 2022-$170.00K–
Q2 FY2022Jun 30, 2022-$1.07M–
Q1 FY2022Mar 31, 2022-$1.80M–
Q4 FY2021Dec 31, 2021-$335.00K–
Q3 FY2021Sep 30, 2021-$910.00K–
Q2 FY2021Jun 30, 2021-$117.00K–
Q1 FY2021Mar 31, 2021-$55.00K–
Q4 FY2020Dec 31, 2020-$1.53M-519.2%
Q3 FY2020Sep 30, 2020-$1.82M–
Q2 FY2020Jun 30, 2020-$1.72M–
Q1 FY2020Mar 31, 2020-$1.84M–
Q4 FY2019Dec 31, 2019$364.00K–
Q3 FY2019Sep 30, 2019-$614.00K–
Q2 FY2019Jun 30, 2019-$1.33M–
Q1 FY2019Mar 31, 2019-$697.00K–
Q4 FY2018Dec 31, 2018-$528.00K-129.4%
Q3 FY2018Sep 30, 2018-$1.12M–
Q2 FY2018Jun 30, 2018-$1.34M–
Q1 FY2018Mar 31, 2018-$669.00K–
Q4 FY2017Dec 31, 2017$1.79M–
Q3 FY2017Sep 30, 2017-$713.00K–
Q2 FY2017Jun 30, 2017-$499.00K–
Q1 FY2017Mar 31, 2017-$659.00K–
Q4 FY2016Dec 31, 2016-$528.00K–
Q3 FY2016Sep 30, 2016-$790.00K–

More Nephros figures

See a number that looks wrong?